Interleukin 16

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Interleukin 16 is a cytokine released by a variety of cells including lymphocytes and epithelial cells expressing the cell surface molecule CD4.

Function[edit | edit source]

It recruits and activates other cells expressing CD4, including lymphocytes, monocytes, and eosinophils.[1]

ME/CFS[edit | edit source]

Landi et al. (2016) found IL-16 to be significantly reduced (downregulated) in long term CFS patients.[2] It is a pro-inflammatory cytokine and the reduction shown may indicate immunodeficiency.
In mice studies low IL-16 is correlated with impaired development of B cells. Most studies into human disease seem to show increases in IL-16 not a decrease (asthma, rheumatoid arthritis, Lupus, MS). The other condition which shows a decrease is HIV and IL-16 may repress HIV-1 replication (Indinavir used in HIV patients increases circulating IL-16). IL-16 has a developmental role in the human immune system. It is also related to neuronal development and may account for brain fog symptoms.

Notable studies[edit | edit source]

  • 2016, Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome[2] - (Full text)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]